$SCOR·8-K

COMSCORE, INC. · Jun 22, 7:17 PM ET

Compare

COMSCORE, INC. 8-K

Research Summary

AI-generated summary

Updated

comScore, Inc. Annual Meeting: Equity Plan Increase Approved; Directors Elected

What Happened

  • comScore, Inc. filed an 8-K reporting the results of its June 16, 2026 annual meeting. Stockholders approved an amendment to the Amended and Restated 2018 Equity and Incentive Compensation Plan to increase the number of shares available for grant by 3,000,000; the amendment became effective June 16, 2026.
  • Two Class I directors were re/elected to terms expiring at the 2029 annual meeting: David Kline and Brian Wendling. Deloitte & Touche LLP was ratified as the company’s independent registered public accounting firm for fiscal 2026. The company also received an advisory “say-on-pay” approval.

Key Details

  • Equity plan amendment: +3,000,000 shares approved (effective June 16, 2026). Detailed terms described in the proxy filed April 30, 2026.
  • Director votes: David Kline — For 22,904,154; Withheld 926,060; Broker non-votes 1,240,084. Brian Wendling — For 22,574,634; Withheld 1,255,580; Broker non-votes 1,240,084.
  • Say-on-pay (non-binding): For 23,119,135; Against 659,092; Abstain 51,987; Broker non-votes 1,240,084.
  • Auditor ratification: For 25,048,171; Against 18,634; Abstain 3,493.
  • Voting note: 8,795,201 shares of Series C Preferred Stock were treated as neutral votes on all proposals per the Certificate of Designations.
  • Form 8-K signed by CFO Mary Margaret Curry on June 22, 2026.

Why It Matters

  • The approved 3,000,000-share increase expands the pool available for employee and executive equity awards, which can support hiring and retention but could lead to incremental dilution if grants are issued.
  • Re-election of directors and ratification of the auditor indicate governance continuity; the advisory approval of executive compensation signals shareholder support for current pay practices.
  • Investors should watch future equity award disclosures and the company’s proxy/SEC filings for details on actual grants and potential dilution.

Loading document...